Propanc Biopharma Inc banner

Propanc Biopharma Inc
NASDAQ:PPCB

Watchlist Manager
Propanc Biopharma Inc Logo
Propanc Biopharma Inc
NASDAQ:PPCB
Watchlist
Price: 3.2797 USD 673.7% Market Closed
Market Cap: $4.8m

Intrinsic Value

The intrinsic value for Propanc Biopharma Inc (PPCB) under the Base Case is 16.5963 USD. Compared with the current market price of 3.2797 USD, the stock appears Undervalued by 80% .

Intrinsic value calculated using DCF
$16.5963

Do our valuations actually work? See backtest results .

PPCB Intrinsic Value
$16.5963
Undervaluation 80%
Intrinsic Value
Price $3.2797
Monitor PPCB
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $13.28
Get notified when the price drops into your buy zone
Intrinsic Value $16.6
Margin of Safety 20% $13.28
Current Price $3.28
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about PPCB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PPCB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Propanc Biopharma Inc.

Explain Valuation
Alternatives to PPCB

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Propanc Biopharma Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one PPCB stock?

The intrinsic value for Propanc Biopharma Inc (PPCB) under the Base Case is 16.5963 USD.

Is PPCB stock undervalued or overvalued?

Compared with the current market price of 3.2797 USD, the stock appears Undervalued by 80% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett